By potentially altering how the brain responds to food-related rewards, it is hypothesised that GLP-1 medications might affect other reward-processing systems
Expert Opinions Endocrinologists Take Dr
Some studies even explore how GLP-1 may reduce addiction cravings, including alcohol use disorder, showing another side of its impact on behavior
By activating GLP-1 receptors, these drugs enhance glucose-dependent insulin secretion, suppress glucagon release, slow gastric emptying, and influence central appetite signaling
This was the first year ICD-10-CM was implemented into the HIPAA code set
The 24% average at the highest dose exceeds tirzepatide, with some participants losing over 30% of body weight